The latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markers

Triple negative breast cancer (TNBC) is one type of breast cancer (BC), which is defined as negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (Her2). Its origins and development seem to be elusive. And for now, drugs like tamoxifen or trastu...

Full description

Saved in:
Bibliographic Details
Published inJournal of thoracic disease Vol. 6; no. 9; pp. 1329 - 1335
Main Authors Jiao, Qingli, Wu, Aiguo, Shao, Guoli, Peng, Haoyu, Wang, Mengchuan, Ji, Shufeng, Liu, Peng, Zhang, Jian
Format Journal Article
LanguageEnglish
Published China Pioneer Bioscience Publishing Company 01.09.2014
Subjects
Review
prognostic marker
therapeutic target
Triple negative breast cancer (TNBC)
risk factor
Online AccessGet full text

Cover

Abstract Triple negative breast cancer (TNBC) is one type of breast cancer (BC), which is defined as negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (Her2). Its origins and development seem to be elusive. And for now, drugs like tamoxifen or trastuzumab which specifically apply to ER, PR or Her2 positive BC seem unforeseeable in TNBC clinical treatment. Due to its extreme malignancy, high recurrence rate and poor prognosis, a lot of work on the research of TNBC is needed. This review aims to summarize the latest findings in TNBC in risk factors, possible therapeutic targets and possible prognostic makers.
AbstractList Triple negative breast cancer (TNBC) is one type of breast cancer (BC), which is defined as negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (Her2). Its origins and development seem to be elusive. And for now, drugs like tamoxifen or trastuzumab which specifically apply to ER, PR or Her2 positive BC seem unforeseeable in TNBC clinical treatment. Due to its extreme malignancy, high recurrence rate and poor prognosis, a lot of work on the research of TNBC is needed. This review aims to summarize the latest findings in TNBC in risk factors, possible therapeutic targets and possible prognostic makers.
Author Peng, Haoyu
Ji, Shufeng
Zhang, Jian
Liu, Peng
Jiao, Qingli
Wu, Aiguo
Wang, Mengchuan
Shao, Guoli
Author_xml – sequence: 1
  givenname: Qingli
  surname: Jiao
  fullname: Jiao, Qingli
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 2
  givenname: Aiguo
  surname: Wu
  fullname: Wu, Aiguo
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 3
  givenname: Guoli
  surname: Shao
  fullname: Shao, Guoli
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 4
  givenname: Haoyu
  surname: Peng
  fullname: Peng, Haoyu
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 5
  givenname: Mengchuan
  surname: Wang
  fullname: Wang, Mengchuan
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 6
  givenname: Shufeng
  surname: Ji
  fullname: Ji, Shufeng
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 7
  givenname: Peng
  surname: Liu
  fullname: Liu, Peng
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
– sequence: 8
  givenname: Jian
  surname: Zhang
  fullname: Zhang, Jian
  organization: 1 Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China ; 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; 3 Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510275, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25276378$$D View this record in MEDLINE/PubMed
BookMark eNpVUU1v1DAQtVARLaV_AVniUiQSbCexEw6V6AooUgWX5RxN7Omu26wdPN5K_Qv8akxbUJnLjGbevDcfL9lBiAEZeyNF3Qymf39de6JQK2FUJdtmKJFsa9HXsnnGjkraVFqr9uA-foAcshOia1FMC6WMecEOVaeMbkx_xH6tt8hnyEiZLyluEhJxH3jxCMlueQw8J7_MyANuIPtb5FNCKHALwWLip-tv56u3H3jydMOvwOaY6B1fIpGfSlfeYoIF99lbniFtMBOH4O7FQqQ_6R2kG0z0ij2_gpnw5NEfsx-fP61XF9Xl9y9fVx8vK9uoNldoZSeccFJL6XTXAbiyS-cGMWmYJujbTuvODNo50FL1k5VWO-W0QignmZpjdvbAu-ynHTqLISeYxyX5MsjdGMGP_1eC346beDu20vRi6AvB6SNBij_35XLjzpPFeYaAcU-j7PoymyjaBfr6qdY_kb8PaH4DzF2RCQ
CitedBy_id crossref_primary_10_5812_rijm_3_2_2015_24992
crossref_primary_10_1007_s11030_017_9731_1
crossref_primary_10_1007_s12010_017_2677_z
crossref_primary_10_5812_archcid_3_2_2015_24992
crossref_primary_10_3390_jcm11030616
crossref_primary_10_1080_15592294_2016_1241932
crossref_primary_10_1007_s10549_020_05730_2
crossref_primary_10_1007_s11064_019_02837_x
crossref_primary_10_3389_fcell_2022_742213
ContentType Journal Article
Copyright 2014 Pioneer Bioscience Publishing Company. All rights reserved. 2014 Pioneer Bioscience Publishing Company.
Copyright_xml – notice: 2014 Pioneer Bioscience Publishing Company. All rights reserved. 2014 Pioneer Bioscience Publishing Company.
DBID NPM
7X8
5PM
DOI 10.3978/j.issn.2072-1439.2014.08.13
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-6624
EndPage 1335
ExternalDocumentID 25276378
Genre Journal Article
Review
GroupedDBID 04C
53G
AAKDD
AAWTL
ACGFO
ADBBV
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BMSDO
DIK
GX1
HYE
M~E
NPM
OK1
RPM
7X8
5PM
ID FETCH-LOGICAL-c324t-ec150d0d1611d655aad7635d90b6abba845665796dda6128bc1c6d2d62ea072b3
IEDL.DBID RPM
ISSN 2072-1439
IngestDate Fri Sep 01 02:22:34 EDT 2023
Fri Aug 16 04:28:13 EDT 2024
Thu May 23 23:19:58 EDT 2024
IsPeerReviewed false
IsScholarly true
Issue 9
Keywords prognostic marker
therapeutic target
Triple negative breast cancer (TNBC)
risk factor
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c324t-ec150d0d1611d655aad7635d90b6abba845665796dda6128bc1c6d2d62ea072b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 25276378
PQID 1586110128
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4178098
proquest_miscellaneous_1586110128
pubmed_primary_25276378
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Journal of thoracic disease
PublicationTitleAlternate J Thorac Dis
PublicationYear 2014
Publisher Pioneer Bioscience Publishing Company
Publisher_xml – name: Pioneer Bioscience Publishing Company
References 20406885 - J Cell Sci. 2010 May 15;123(Pt 10):1716-23
23179496 - J Cancer Surviv. 2013 Mar;7(1):74-82
23700430 - PLoS One. 2013 May 20;8(5):e63712
21402910 - Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5384-9
23696021 - Med Oncol. 2013;30(3):612
21278435 - Oncologist. 2011;16 Suppl 1:1-11
20664514 - Cancer Control. 2010 Jul;17(3):173-6
20813035 - Breast Cancer Res. 2010;12(5):R68
21620960 - Cell Signal. 2011 Oct;23(10):1515-27
23139210 - Cancer Res. 2012 Nov 15;72(22):5812-23
19778431 - BMC Cancer. 2009 Sep 24;9:342
17387718 - Cancer. 2007 May 1;109(9):1721-8
19728229 - Ultrastruct Pathol. 2009 Jul-Aug;33(4):141-50
11454684 - Cancer Res. 2001 Jul 15;61(14):5407-14
23932548 - Lancet Oncol. 2013 Sep;14(10):933-42
23939688 - Int J Oncol. 2013 Oct;43(4):985-94
22992276 - BMC Cancer. 2012 Sep 19;12:414
22276821 - N Engl J Med. 2012 Jan 26;366(4):310-20
20556505 - Breast Cancer Res Treat. 2011 May;127(1):99-108
23845466 - Hum Pathol. 2013 Oct;44(10):2180-7
23807420 - Breast Cancer Res Treat. 2013 Jul;140(1):93-104
23509284 - Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):E1301-10
24684785 - Breast Cancer Res. 2014 Mar 31;16(2):R32
22156446 - Onkologie. 2011;34(12 ):675-80
19320967 - Breast Cancer Res. 2009;11(2):R18
23828443 - Arch Gynecol Obstet. 2014 Jan;289(1):141-7
17189395 - Clin Cancer Res. 2006 Dec 15;12(24):7242-51
17578664 - Breast Cancer Res Treat. 2008 May;109(1):123-39
17620276 - Cancer. 2007 Aug 15;110(4):876-84
20336785 - Cancer. 2010 Jun 1;116(11):2549-59
17671126 - Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
7602345 - J Clin Oncol. 1995 Jul;13(7):1572-7
18826621 - BMC Cancer. 2008 Sep 30;8:278
24265703 - PLoS One. 2013 Nov 12;8(11):e78641
17714947 - Breast. 2007 Dec;16 Suppl 2:S72-7
23836011 - Breast Cancer Res Treat. 2013 Jul;140(2):353-61
21270527 - Cell Cycle. 2011 Feb 1;10(3):507-17
21387260 - Cancer. 2011 Aug 15;117(16):3658-69
12960130 - Clin Cancer Res. 2003 Aug 15;9(9):3413-7
23740185 - Swiss Med Wkly. 2013 May 28;143:w13765
19685490 - Int J Cancer. 2010 Mar 1;126(5):1121-31
15372205 - Cancer Immunol Immunother. 2005 Mar;54(3):254-64
16983337 - Oncogene. 2007 Mar 15;26(12):1693-701
23236502 - PLoS One. 2012;7(12):e51446
23697991 - Clin Cancer Res. 2013 Jul 1;19(13):3703-13
17372238 - Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):439-43
21440529 - Biochem Biophys Res Commun. 2011 Apr 22;407(4):680-6
19901010 - Ann Oncol. 2009 Dec;20(12):1913-27
21732535 - EMBO Mol Med. 2011 Sep;3(9):528-44
19534825 - BMC Cancer. 2009 Jun 18;9:192
20060649 - Cancer Treat Rev. 2010 May;36(3):206-15
23646186 - PLoS One. 2013 Apr 30;8(4):e63132
24325915 - Carcinogenesis. 2014 May;35(5):1012-9
18324472 - Breast Cancer Res Treat. 2009 Jan;113(2):357-70
22982153 - J Steroid Biochem Mol Biol. 2013 Jan;133:66-76
23933800 - Breast Cancer Res Treat. 2013 Aug;141(1):89-99
23845471 - Hum Pathol. 2013 Oct;44(10):2159-66
17968031 - Cancer Res. 2007 Nov 1;67(21):10608-17
23946688 - Korean J Physiol Pharmacol. 2013 Aug;17(4):291-7
19088017 - Clin Cancer Res. 2008 Dec 15;14(24):8010-8
23000897 - Nature. 2012 Oct 4;490(7418):61-70
19182542 - Fly (Austin). 2009 Jan-Mar;3(1):62-7
16757721 - JAMA. 2006 Jun 7;295(21):2492-502
10963602 - Nature. 2000 Aug 17;406(6797):747-52
23406733 - Ann Oncol. 2013 Jun;24(6):1498-505
18250347 - J Clin Oncol. 2008 Mar 10;26(8):1275-81
References_xml
SSID ssj0000602277
Score 2.2437904
SecondaryResourceType review_article
Snippet Triple negative breast cancer (TNBC) is one type of breast cancer (BC), which is defined as negative for estrogen receptor (ER), progesterone receptor (PR) and...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1329
SubjectTerms Review
Title The latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markers
URI https://www.ncbi.nlm.nih.gov/pubmed/25276378
https://search.proquest.com/docview/1586110128
https://pubmed.ncbi.nlm.nih.gov/PMC4178098
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB0Bh4oLYqdsGgQHkEibpHEWblBRISQQB5C4VV5SKKJO1Yaf4KuZcVJUECfOjuPIM2O_id88A5xEhFF9FfveINeUoKhAe0oOtMebxcCEvsyMI8jexzdP0e2zeF4AMauFcaR9rYYt-z5q2eGr41aOR7o944m1H-66UZCkfpa2F2Ex6XTmUvRq-WVVPC6TDv0k9AgPZA045uyUEqb2m4ut1ncTk7siFvEM-EadUIQUb0n6F9z8zZqc24Z6q7BS40e8rL5zDRZyuw6Nu_qEfAM-ye74zgCyRMe9opUMhxZrUZ9XLCyWE_67jjZ_carfqJiYXqJmB5jg6eP9VffsApl0jvV1POc4Ljh4qNdcwRZWNPIpSmvcYLZg1WccMeVnMt2Ep971Y_fGq-9b8DTBqtIjawnf-IZAYGBiIaQ0LFdnMjKmVEqmBLZirl01RhIwSpUOdGxCE4e5pPlUnS1YsoXNdwATkeWaXhRrE0VS-lIQTlRaBwMjIiXDJhzNJrhP_syHFNLmxce0H4iUhudtswnb1YT3x5XwRn9mniYkP0zx_QBrZf9sIRdymtm1y-z-u-ceLLOrVPSyfVgqJx_5AeGRUh06__sCjSziXQ
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIhUulDeBAoPgAFLt2MbrR28logrQRBxS1Ju1D4embdZR4lz4CfxqZtZ2lVZc4LzeXa1mZvcb7zffAryLCaMGKgm8aakpQVGh9pScao8Pi6mJApkbR5AdJ8OT-OupON0C0dXCONK-VjPfXs59Oztz3MrFXPc7nlj_-2gQh2kW5Fn_FtymeI3SjSS92YBZF48LpaMgjTxCBPkOvOX8lFKm_rmLLv-qieldMct4hvymTiQiirg0-xvgvMmb3DiIjnbhR7eEhn9y4a9r5etfN9Qd_3mN9-FeC03xsGl-AFulfQg7o_by_RH8JpfCS8amNTpaF22SOLPY6gWdYWWxXvKPe7TlTycojoo57zVq9q0lvp-MPw0-HCDz2bF96WcfFxXHJfXaqAXDhqG-QmmNm8xWLCiNc2YTLVeP4eTo82Qw9NqnHDxNiK32yBFEYAJD-DI0iRBSGlbCMzn5iVRKZoTjEi6LNUYS5sqUDnViIpNEpSRDqY9PYNtWtnwGmIq81DRQok0cSxlIQRBUaR1OjYiVjHrwprNcQaHC9x_SltV6VYQio-n5RO7B08aSxaLR9Cg6u_cgvWbjqw9Yhvt6C1nOyXG3lnr-3z1fw53hZHRcHH8Zf3sBd9kfGxbbHmzXy3X5kmBPrV45J_8DU4IEaQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswEB20KWD0ku6Nu07RHlqg2lhRS2-tWyNdYuSQAEEvAhepcRJThi1f8gn96sxIcuAEPeVMUgQxM-Qb8fENwLuYMGqok9CrSkMJio6Mp1VlPD4sKitClduWIDtJdg_jn0fyaKPUV0vaN3rqu7OZ76bHLbdyPjPBmicW7O-N4ijNwjwL5rYKbsMdilmRbyTq3SbM2nj8WFqEqfAIFeQDeMs5KqVNwUkbYf5lE1O8YpbyjLiujpCCoi7N_gc6r3MnNw6j8T34s15Gx0E59VeN9s35NYXHG63zPmz3EBW_dF0ewK3SPYTBXn8J_wj-kWvhGWPUBlt6F22WOHXY6wYdY-2wWfAPfHTl31ZYHDVz3xs07GMLfH8w-Tr68BmZ1459xZ-POK85PmnUxpsw7JjqS1TOtpO5moWlccasosXyMRyOvx-Mdr2-pINnCLk1HjmEDG1oCWdGNpFSKcuKeDYnf1Faq4zwXMLPY61VhL0ybSKTWGETUSoylv70BLZc7codwFTmpaEPJcbGsVKhkgRFtTFRZWWslRjCm7X1CgoZvgdRrqxXyyKSGU3PJ_MQnnbWLOadtkextv0Q0it2vuzActxXW8h6rSx3b61nNx75Ggb738bF7x-TX8_hLrtkR2Z7AVvNYlW-JPTT6Fetn18AacUG6Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+latest+progress+in+research+on+triple+negative+breast+cancer+%28TNBC%29%3A+risk+factors%2C+possible+therapeutic+targets+and+prognostic+markers&rft.jtitle=Journal+of+thoracic+disease&rft.au=Jiao%2C+Qingli&rft.au=Wu%2C+Aiguo&rft.au=Shao%2C+Guoli&rft.au=Peng%2C+Haoyu&rft.date=2014-09-01&rft.issn=2072-1439&rft.eissn=2077-6624&rft.volume=6&rft.issue=9&rft.spage=1329&rft_id=info:doi/10.3978%2Fj.issn.2072-1439.2014.08.13&rft_id=info%3Apmid%2F25276378&rft.externalDocID=25276378
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-1439&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-1439&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-1439&client=summon